International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.13687834
Original Research Article
A STUDY OF SEROPREVALENCE OF JAPANESE ENCEPHALITIS CASES IN A TERTIARY CARE HOSPITAL, CHANDRAPUR, MAHARASHTRA
Published
Jan. 22, 2025
Abstract

Globally, arboviruses are the cause of viral encephalitis. Japanese encephalitis is common throughout India. Tamil Nadu, Andhra Pradesh, Uttar Pradesh, Bihar, Assam, West Bengal, Karnataka, Goa, and Maharashtra are among the Indian states where cases have been documented. The current study intended to determine the prevalence of Japanese encephalitis in patients at a tertiary care facility who had received a clinical diagnosis of viral encephalitis. The disease was first identified in Nagpur (1952) which is closer to chandrapur, where it was found that an unidentified viral encephalitis, later identified as JEV, a flavivirus spread by mosquitoes, had killed about 16 people. In the current study, amongst 68 samples,7 males and 2 females were tested positive. In September month the highest number of suspected cases were noted. Children aged 1 to 5 accounted for most JEV-affected individuals, and as age increased, fewer seropositive instances were reported. In places affected by the JE epidemic, immunizations' crucial role might also be cross-checked. Therefore, it may also be advantageous to include the JE Vaccine in routine vaccination programs in places where JEV is an epidemic.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
1507 Views
179 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved